Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) CFO Kenneth Allen Myszkowski Sells 27,167 Shares
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) CFO Kenneth Allen Myszkowski sold 27,167 shares of the company’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $19.83, for a total transaction of $538,721.61. Following the completion of the transaction, the chief financial officer now owns 473,433 […]
More Stories
Top Streaming Stocks To Research – June 6th
NVIDIA, AppLovin, Spotify Technology, Trade Desk, Walt Disney, Roku, and Comcast are the seven Streaming stocks to watch today, according...
Top Infrastructure Stocks To Consider – June 6th
NVIDIA, Broadcom, Alphabet, Applied Digital, and Coinbase Global are the five Infrastructure stocks to watch today, according to MarketBeat’s stock...
Hennion & Walsh Asset Management Inc. Makes New $790,000 Investment in SAP SE (NYSE:SAP)
Hennion & Walsh Asset Management Inc. bought a new position in shares of SAP SE (NYSE:SAP – Free Report) during...
NBC Securities Inc. Increases Stake in Vanguard FTSE All-World ex-US ETF (NYSEARCA:VEU)
NBC Securities Inc. grew its position in shares of Vanguard FTSE All-World ex-US ETF (NYSEARCA:VEU – Free Report) by 97,375.0%...
Merit Financial Group LLC Boosts Holdings in SAP SE (NYSE:SAP)
Merit Financial Group LLC increased its holdings in SAP SE (NYSE:SAP – Free Report) by 71.0% during the first quarter,...
Merit Financial Group LLC Grows Holdings in Robinhood Markets, Inc. (NASDAQ:HOOD)
Merit Financial Group LLC grew its holdings in Robinhood Markets, Inc. (NASDAQ:HOOD – Free Report) by 31.7% during the first...